Hold Sun Pharma; target of Rs 775: Emkay Global Financial Dayanand Saini | January 12, 2022 | Finacial News | No Comments Emkay Global Financial recommended hold rating on Sun Pharma with a target price of Rs 775 in its research report dated January 10, 2022. Related Posts Buy Hindalco Industries: target of Rs 550: ICICI Securities No Comments | Dec 23, 2021 Sell Vodafone Idea; target of Rs 6: ICICI Direct No Comments | Feb 18, 2021 Buy Axis Bank; target of Rs 875: Dolat Capital Market No Comments | May 15, 2021 Hold Motherson Sumi; target of Rs 150: ICICI Direct No Comments | Dec 8, 2020 About The Author Dayanand Saini